Moreno-Galindo, Carla <br/><br/>
p27 and BCL2 expression predicts response to chemotherapy in head and neck squamous cell carcinomas.  [electronic resource] 

 -  Oral oncology  Feb 2014 
 - 128-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0593 
<br/><br/><label>Standard No.: </label>10.1016/j.oraloncology.2013.10.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antimetabolites, Antineoplastic--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor--metabolism<br/>Carcinoma, Squamous Cell--drug therapy<br/>Caspase 3--metabolism<br/>Cisplatin--therapeutic use<br/>Cyclin D1--metabolism<br/>Cyclin-Dependent Kinase Inhibitor p16<br/>Cyclin-Dependent Kinase Inhibitor p21--metabolism<br/>ErbB Receptors--metabolism<br/>Female<br/>Fluorouracil--therapeutic use<br/>Humans<br/>Hypopharyngeal Neoplasms--drug therapy<br/>Hypoxia-Inducible Factor 1, alpha Subunit--metabolism<br/>Laryngeal Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Proteins--metabolism<br/>Prognosis<br/>Proliferating Cell Nuclear Antigen--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Tumor Suppressor Protein p53--metabolism